Vascular Biogenics Ltd. (VBLT) Q4 2018 Results Conference Call March 28, 2019 8:30 AM ET
Company Participants
Michael Wood - LifeSci Advisors
Dror Harats - CEO
Amos Ron - CFO
Erez Feige - VP of Business Operations
Conference Call Participants
Swayampakula Ramakanth - H.C. Wainwright
Geulah Livshits - Chardan
Soumit Roy - Jones Trading
Michael Wood
Thank you, Operator. And thank you all for participating in today’s Full Year 2018 Results and Corporate Update Conference Call. Leading the call today will be Dr. Dror Harats, CEO of VBL Therapeutics and Amos Ron, the Company's CFO. Erez Feige, VP of Business Operations is also on the call. A press release with the Company's financial results became available this morning on the Newswire that can be found on the Investor Relations page of the Company's Web site at vblrx.com.
Before we begin, I'd like to remind everyone that various remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. VBL cautions that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated. Any forward-looking statements made on this conference call speak only as of today's date, Thursday, March 28, 2019 and the Company does not intend to update any of these forward-looking statements to reflect events or circumstances that occur after today's date.
As a reminder, this call is being recorded and will be available for audio replay on the company’s Web site. As the operator mentioned, all participants are currently in a listen-only mode and there will be a Q&A session following the company’s prepared remarks.
With that, I’d like to turn the call over to Prof. Dror Harats, CEO of VBL. Dror, please go ahead.
- Read more current VBLT analysis and news
- View all earnings call transcripts